biote Corp.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $192.2M | $197.2M | $185.4M | $165.0M | $139.4M |
| Operating income | $35.6M | $31.6M | $28.7M | -$60.7M | $34.6M |
| Cash from operations | $35.2M | $45.2M | $26.9M | -$9.2M | $33.7M |
| Capital expenditure | $5.0M | $6.4M | $359,000 | $333,000 | $1.4M |
| Free cash flow | $30.2M | $38.8M | $26.5M | -$9.5M | $32.3M |
| Share repurchases | $3.4M | $5.6M | — | — | — |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $107.6M | $122.4M | $155.3M | $111.6M | $54.3M |
| Total liabilities | $158.0M | $224.6M | $191.8M | $169.9M | $50.2M |
| Total debt | $103.1M | $109.4M | $115.6M | $121.9M | $37.5M |
Shares outstanding 37.6M · Free float 71.1%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.